| 1 |
王海燕. 肾脏病学[M]. 北京: 人民卫生出版社, 2008.
|
| 2 |
刘玲, 刘辉辉, 刘滇军, 等. 早期糖尿病肾病肾小球内皮功能紊乱的机制[J]. 现代中西医结合杂志, 2013, 22 (25):2749-2751+2756.
|
| 3 |
Schrezenmeier EV, Barasch J, Budde K, et al. Biomarkers in acute kidney injury - pathophysiological basis and clinical performance[J]. Acta Physiol (Oxf), 2017, 219 (3):554-572.
|
| 4 |
Zhang L, Pang S, Deng B, et al. High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NF-κB/NADPH oxidase/ROS pathway, which is inhibited by resveratrol[J]. International J Biochem Cell Biol, 2012, 44 (4):629-638.
|
| 5 |
Eid AA, Koubeissi A, Bou-Mjahed R, et al. Novel carbocyclic nucleoside analogs suppress glomerular mesangial cells proliferation and matrix protein accumulation through ROS-dependent mechanism in the diabetic milieu[J]. Bioorg Medicinal Chem Lett, 2013, 23 (1):174-178.
|
| 6 |
Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery[J]. Lancet, 2005, 365 (9466):1231-1238.
|
| 7 |
Che M, Xie B, Xue S, et al. Clinical usefulness of novel biomarkers for the detection of acute kidney injury following elective cardiac surgery[J]. Nephron Clin Pract, 2010, 115 (1):66-72.
|
| 8 |
Bakal Ü, Sarac M, Tartar T, et al. A study of the utility of novel non-invasive urinary and serum biomarkers of blunt kidney injury in a rat model: NGAL, KIM-1, and IL-18[J]. Cent Eur J Immunol, 2019, 44 (3):219-225.
|
| 9 |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中华糖尿病杂志, 2018, 10 (1):4-67.
|
| 10 |
Kanwar YS, Sun L, Xie P, et al. A glimpse of various pathogenetic mechanisms of diabetic nephropathy[J]. Ann Rev Pathol,2011, 6:395-423.
|
| 11 |
蔡文娟, 李洋, 门岚, 等. 尿微量白蛋白/肌酐比值对糖尿病肾病早期诊断价值[D]. 中国实验诊断学, 2013, 17(9):1650-1653.
|
| 12 |
高志飞. 24 h尿微量蛋白和血清Cys C联合检测对2型糖尿病早期肾损伤的诊断价值[J].检验医学与临床, 2019, 16 (23):41.
|
| 13 |
杨春杰, 胡晓娇, 崔琦.随机测定尿微量白蛋白与尿肌酐比值对妊娠期糖尿病患者早期肾损伤的诊断价值[J]. 中国妇幼保健, 2017, 32 (11):2320-2323.
|
| 14 |
Kaneto H, Nakatani Y, Kawamori D, et al. Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic β-cell dysfunction and insulin resistance[J]. International J Biochem Cell Biol, 2005, 37 (8):1595-1608.
|
| 15 |
Kajimoto Y, Kaneto H. Role of oxidative stress in pancreatic beta-cell dysfunction[J]. Ann N Y Acad Sci, 2004, 1011:168-176.
|
| 16 |
Mårtensson J, Xu S, Bell M, et al. Immunoassays distinguishing between HNL/NGAL released in urine from kidney epithelial cells and neutrophils[J]. Clinica Chimica Acta, 2012, 413 (19-20):1661-1667.
|
| 17 |
Shang W, Wang Z. The update of NGAL in acute kidney injury[J]. Curr Protein Pept Sci, 2017, 18 (12):1211-1217.
|
| 18 |
孙蔚倩, 胡屏, 贺海东, 等. 血清、尿NGAL与慢性肾小球肾炎临床和病理相关性研究[J]. 中国中西医结合肾病杂志, 2019, 20 (8):724-725.
|
| 19 |
罗红艳, 闫学慧, 陆晓华, 等. 尿NGAL与慢性肾脏病进展的相关分析[J]. 宁夏医学杂志, 2020, 42 (3):232-234.
|
| 20 |
Ichimura T, Bonventre J V, Bailly V, et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury[J]. J Biol Chem, 1998, 273 (7):4135-4142.
|
| 21 |
黄楔山, 孙自国, 李艳, 等. 尿肾损伤分子-1和可溶性髓样细胞触发受体-1对脓毒症相关急性肾损伤的早期诊断价值[J]. 临床急诊杂志, 2020, 21 (6):488-492+498.
|
| 22 |
严丽君. 血清半胱氨酸蛋白酶抑制剂C及尿肾损伤分子-1在心肺旁路术后急性肾损伤早期诊断中的临床研究[D]. 汕头大学, 2009.
|
| 23 |
Tanase DM, Gosav EM, Radu S, et al. The predictive role of the biomarker kidney molecule-1 (KIM-1) in acute kidney injury (AKI) cisplatin-induced nephrotoxicity[J]. Int J Mol Sci, 2019, 20 (20):5238.
|